RxDoctor Payments Data

Mohamed Shama, MD

Surgical Oncology · New Orleans, LANPI 1659807972

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $1,500 of the $2,272 with a category attached, or 66.0%. Medical Device Business Services, Inc. accounts for 66.0% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2019 at $1,500 and has fallen 92.7% since, to $110 in 2025. That places this record below the midpoint for surgical oncology clinicians in LA, where the typical reported total is $3,103.

$2,272in general payments, 2019–2025

Across 14 payments — averaging $162.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medical Device Business Services, Inc.$2K
  • Olympus America Inc.$193
  • Medtronic$171
  • Boston Scientific$110
  • Johnson & Johnson$106
  • Exelixis Inc.$87
  • plus $104 from 2 others

What the payments were for

  • Travel & lodging$1,50066%
  • Food & beverage$77234%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,272 in reported general payments places this provider in the 45th percentile of 26 surgical oncology providers in Louisiana.

See all surgical oncology providers in Louisiana

Medicare billing

Part B allowed, 2024
$15,666
Medicare patients
21
Services billed
74

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other surgical oncology in New Orleans

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →